Consignment bioequivalence testing will likely be scrapped in May

The planned scrapping of consignment bioequivalence testing to ensure its transparency and facilitate the development of generic drugs will be available in May through a variety of procedures under the newly revised rules concerning the safety and efficacy of drugs, etc., according to Korea Food and Drug Administration (KFDA).

The health regulator said that its detailed procedure will be mad...